TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.340
+0.040 (3.08%)
At close: Nov 20, 2024, 4:00 PM
1.370
+0.030 (2.24%)
After-hours: Nov 20, 2024, 4:21 PM EST

TherapeuticsMD Revenue

TherapeuticsMD had revenue of $547.00K in the quarter ending September 30, 2024, a decrease of -1,132.08%. This brings the company's revenue in the last twelve months to $1.60M, down -97.70% year-over-year. In the year 2023, TherapeuticsMD had annual revenue of $1.30M, down -98.14%.

Revenue (ttm)
$1.60M
Revenue Growth
-97.70%
P/S Ratio
9.58
Revenue / Employee
$1,596,000
Employees
1
Market Cap
15.45M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.30M-68.66M-98.14%
Dec 31, 202269.96M67.39M2,619.12%
Dec 31, 20212.57M-62.30M-96.03%
Dec 31, 202064.87M15.23M30.67%
Dec 31, 201949.65M33.55M208.38%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Flora Growth 64.15M
Cumberland Pharmaceuticals 36.79M
Lifeward 25.00M
Ekso Bionics Holdings 17.68M
Can-Fite BioPharma 667.00K
Revenue Rankings